Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Next-generation Sequencing03:00

Next-generation Sequencing

92.6K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
92.6K
Genomics02:02

Genomics

37.4K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
37.4K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

14.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.1K
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

17.9K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.9K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Parenting stress and children's problematic media use: An analysis based on the common fate model.

Journal of family psychology : JFP : journal of the Division of Family Psychology of the American Psychological Association (Division 43)·2026
Same author

Non-invasive assessment of coronary inflammation improves the diagnostic accuracy of coronary death in post-mortem CT angiography.

Journal of cardiovascular computed tomography·2026
Same author

Integrative Multi-Omics and Machine Learning Analysis Identifies Therapeutic Targets and Drug Repurposing Candidates for Alzheimer's Disease.

Biomedicines·2026
Same author

Development and content validation of the Clinician-reported Genetic testing Utility InDEx for genomic newborn screening (C-GUIDE NBS).

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Fluoride-Initiated Annulation of Alkynoates and Trifluoromethyl Alkenes.

Organic letters·2026
Same author

An X-linked long non-coding RNA, PTCHD1-AS, and the core features of autism.

Nature·2026

関連する実験動画

Updated: Sep 10, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.0K

遺伝子診断のためのゲノムシーケンシングとエクソームシーケンシングを比較するランダム化試験によるマイクロコストとコスト結果分析

Wendy J Ungar1, Vercancy Wu1, Christian R Marshall2

  • 1Program in Child Health Evaluative Sciences, Hospital for Sick Children Research Institute, Toronto, ON, Canada.

Genetics in medicine : official journal of the American College of Medical Genetics
|August 25, 2025
PubMed
まとめ

ゲノムシーケンシング (GS) は,珍しい疾患の診断にエクソームシーケンシング (ES) よりも高価で,同様の診断結果が得られます. GSによって唯一検出可能な変種を評価するには,さらなる研究が必要です.

キーワード:
RCT について診断用収量エクソームシーケンシングゲノムシーケンシングマイクロコスティング

さらに関連する動画

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.5K
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.0K

関連する実験動画

Last Updated: Sep 10, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.0K
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.5K
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.0K

科学分野:

  • ゲノミクス
  • 医学経済学
  • 希少 疾患 の 診断

背景:

  • 希少疾患の診断は 経済的にも大きな課題です
  • 医療従事者にとって 異なる遺伝子配列解析の費用対効果を理解することは 極めて重要です

研究 の 目的:

  • マイクロコスト エクソームシーケンシング (ES) と ゲノムシーケンシング (GS) で 希少疾患の診断を行う.
  • 組織的な支払者の観点から,GSとESの追加診断コストを推定する.

主な方法:

  • ランダムに割り当てられたトリオ (プロンブと親) はESかGSである.
  • 実験室のワークフローとシーケンスのマイクロカスタリング
  • 効果の尺度として診断収率を用いて,トリオ毎の総コストとカテゴリーコストを推定する.

主要な成果:

  • ESの平均総コストは2888.79 CAD,GSの平均総コストは4364.02 CADでした.
  • 反応剤のコストはESの34%,GSの61%を占めた.
  • GSのインクリメンタルコストは1475.23 CADで,ESの35.9%と比較して診断収率は32.7%でした.

結論:

  • ゲノムシーケンシング (GS) はエクソームシーケンシング (ES) よりもコストが高く,この研究でも同様の診断結果が得られました.
  • 試験時の技術的な限界がGSの診断結果に影響を及ぼした可能性があります.
  • 発見は,診断戦略を比較するために重要なコストデータを提供し,GSによって唯一識別された変種を探求する必要性を強調します.